Literature DB >> 18489945

Echocardiographic evaluation and surgical implications of common atrioventricular canal defects with absent or diminutive ostium primum defect.

Avnit Kaur1, Shubhika Srivastava, Irene D Lytrivi, Khanh Nguyen, Wyman W Lai, Ira A Parness.   

Abstract

Common atrioventricular canal defects without ostium primum defects are rare, and their accurate identification has important surgical implications. Retrospective echocardiographic database review identified subjects with common atrioventricular canal defects with absent or diminutive ostium primum defects. Surgical reports and initial and postoperative echocardiograms were reviewed to identify the imaging planes necessary to characterize this anomaly and the surgical challenges imposed by the diagnosis. Fourteen subjects were identified (93% with trisomy 21) with either absent (n = 6) or diminutive (n = 8) ostium primum defects. Malaligned conal septum was present in 50% of subjects with absent primum defects and 12.5% of subjects with diminutive defects. Immediate or long-term complications of the 11 postoperative patients included atrioventricular block (n = 4) and moderate (n = 5) or severe (n = 3) mitral regurgitation. In conclusion, echocardiographic features for the identification of common atrioventricular canal defects with absent or diminutive ostium primum defects are described. Surgical challenges involve attaining adequate exposure of the mitral component and achieving mitral valve competence.

Entities:  

Mesh:

Year:  2008        PMID: 18489945     DOI: 10.1016/j.amjcard.2008.01.049

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  2 in total

1.  Complete atrioventricular canal with guarded primum septal defect.

Authors:  Susheel Kumar; Mary Donofrio; Lowell Frank; Dingchao He; Richard Jonas
Journal:  Pediatr Cardiol       Date:  2010-12-25       Impact factor: 1.655

2.  Isolated Mitral Cleft in Trisomy 21: An Initially 'Silent' Lesion.

Authors:  Poonam P Thankavel; Claudio Ramaciotti
Journal:  Pediatr Cardiol       Date:  2015-10-20       Impact factor: 1.655

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.